AKAsli Koskderelioglu

Asli Koskderelioglu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Asli Koskderelioglu has a total of 62 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Physical and psychological burden in RRMS: depression and fatigue beyond disease duration

    by Neslihan Eskut, Ekin Aydin Demir, Asli Koskderelioglu, Atalay Aktuna

    Multiple sclerosis (MS) is a chronic, autoimmune, demyelinating and neurodegenerative disease. Accumulation of physical and psychological disabilities adversely affects patients' health-related quality of life. The 29-item Multiple Sclerosis Impact Scale (MSIS-29) is a self-reported measure of the physical and psychological burden. To evaluate the physical and psychological impact levels in patients with MS and to examine their relationship with disease duration. We enrolled 100 consecutive adults aged 18 to 55 years with relapsing-remitting MS (RRMS). The Expanded Disability Status Scale (EDSS), annual relapse rate (ARR), Beck Depression Inventory (BDI), Fatigue Severity Scale (FSS), MSIS-29, and Timed 25-Foot Walk Test (25-FWT) were applied. A total of 57 participants (57%) were female patients. The mean age was 38.5 ± 8.0 years, and the mean disease duration, 9.8 ± 6.8 years. The mean MSIS-29 physical and psychological scores were 36.7 ± 15.7 and 45.3 ± 20.4 respectively. No significant differences were found between patients with disease duration ≤ 10 and > 10 years in terms of the physical (p = 0.263) or psychological (p = 0.551) subscales. Physical impact was significantly associated with the female sex (p = 0.021) and the scpres on the EDSS (p = 0.030), BDI (p < 0.001), and FSS (p < 0.001). Psychological impact showed significant associations with the female sex (p = 0.005), ARR (p = 0.020), and the scores on the BDI (p < 0.001), and FSS (p < 0.001). On multivariate regression, the scores on the EDSS, BDI, and 25-FWT were independent predictors of physical impact, while the female sex and the scores on the EDSS and BDI were independent predictors of psychological impact. Disease duration did not predict physical or psychological impact in RRMS. Depression severity, lower-extremity function, and the female sex were the independent determinants of disease-related impact in the multivariate analysis. The association of fatigue with disease impact, significant at the bivariate level, was attenuated by depression in the multivariate analysis. Routine assessment of these modifiable factors should be accompanied by disease-modifying treatments in MS care.

  • MULTIPLE SCLEROSIS AND AUTOANTIBODY POSITIVITY: DIAGNOSTIC VALUE AND CLINICAL IMPLICATIONS

    by Levent Öcek, İrEm Eylül Kırdı, Elif Gonca Bektaş, Neslihan Eşkut, Aslı Köşkderelioğlu, Pınar Ortan

    Introduction: Multiple sclerosis (MS) is a chronic disease characterized by autoimmune, inflammatory, and neurodegenerative processes affecting the central nervous system. In recent years, increasing attention has been drawn to the coexistence of autoantibody positivity and other autoimmune diseases in MS patients. This study aimed to evaluate the frequency of autoantibody positivity in MS patients and its relationship with clinical, laboratory, and radiological features. Methods: Patients who were evaluated with a preliminary diagnosis of MS and continued regular follow-up in our clinic between November 2023 and February 2025 were included. Patients were divided into two groups according to the presence of autoantibody positivity. Demographic, clinical (Expanded Disability Status Scale [EDSS], history of concomitant autoimmune disease), laboratory, and magnetic resonance imaging (MRI) findings were compared. Results: A total of 68 patients were included, of whom 46 (67.6%) were female, with a mean age of 36.26±11.51 years. Relapsing-remitting MS was identified in 76.5% (n=52) of patients. The most common clinical manifestation was sensory symptoms, observed in 48.5%. Autoantibody positivity was detected in 27.9% of patients, with antinuclear antibody (ANA) being the most frequently positive (11.8%). Autoantibody positivity was significantly higher in females (p=0.017), and concomitant autoimmune disease was more frequent in this group (p=0.047). No significant differences were observed between groups regarding MS subtype, initial symptoms, EDSS score, MRI lesion distribution, or cerebrospinal fluid findings (p>0.05). Conclusion: A considerable proportion of MS patients exhibited autoantibody positivity, which was particularly associated with female sex and the presence of concomitant autoimmune diseases. Although autoantibody positivity was not predictive of clinical phenotype or disease severity, it may reflect systemic autoimmune susceptibility. These findings highlight the need for larger, prospective studies to elucidate the role of autoantibodies in MS pathogenesis

  • Workplace difficulties and coping strategies in multiple sclerosis: insights from a Non-Western population

    by Ekin Aydin Demir, Neslihan Eskut, Asli Koskderelioglu, Atalay Aktuna

    Introduction and objectives Multiple sclerosis (MS) is a chronic neurologic disease that primarily affects adults of working age. Symptoms related to the disease can lead to unemployment and challenges in the workplace. This study aims to review the challenges related to work life in actively working adult patients with MS, and investigate the relationship of these challenges with disease-related factors such as cognitive, emotional, and physical disability, as well as the coping strategies employed. Methods One hundred fifty patients with a definitive diagnosis of relapsing-remitting multiple sclerosis (RRMS) were included in the study. We evaluated fatigue, cognition, mood, extremity functions, disability, and coping strategies for difficulties at work. Results In our study, as patients’ cognitive levels decreased, their scores on psychological/cognitive barriers, physical barriers, and total barriers increased. We found a negative correlation between work-related difficulties and patients’ cognitive levels. As patients’ scores on depression, fatigue, and hopelessness tests increased, their scores across all work-related barriers also increased. Conclusion This study highlights the importance of evaluating the clinical symptoms, work-related challenges, and coping strategies in the follow-up of working patients with MS. Therefore, we suggest prioritizing adaptive coping and vocational rehabilitation to mitigate work-related difficulties.

  • Stiff Person Syndrome

    by Gizemnur Filinta, Asli Koskderelioglu, Neslihan Eskut, Fikriye Elif Saka, Bugra Ince

    Stiff person syndrome (SPS) is an autoimmune disease emerged by lack of inhibition to excitatory neurotransmitters in the central nervous system often due to antibodies against glutamic acid decarboxylase (GAD). Fluctuating and progressive muscle rigidity, spasms and also stiffness are common manifestations. The pathophysiology of SPS is not fully understood but however, high titers of anti-GAD antibodies are strongly associated with this syndrome and immunological treatment helps to improve the rigidity, painfully spasms and stiffness. Here we present a case of a 61 years old female patient diagnosed with positive anti-GAD65 antibodies SPS. In the context of a severely disabling disease manifestation, we analyze the case presentation and treatment strategies. A 61-year-old female patient presented with recent falls, muscle contractions and pain in the lower extremities. Neurological examination revealed severe rigidity and painful spasms of the lower extremities and reactive spasms to touch were present. Full blood count, routine biochemistry, cerebrospinal fluid (CSF) analyze were normal. Electromyography (EMG) demonstrated a continuous motor unit activity of whole lower extremity muscles. According to EMG findings our preliminary diagnosis was SPS. Anti-GAD antibodies were detected positive. This finding reinforced the diagnosis of anti-GAD-associated SPS. Diazepam, clonazepam, plasmapheresis and also intravenous immun globulin was administered step by step. She did not get any significant benefit from any of treatments. Treatment with rituximab was planned but the patient was admitted to the intensive care unit due to pulmonary embolism and respiratory distress caused by COVID infection. Unfortunately, Rituximab could not be administered due to the patient's poor general condition. SPS remains an important consideration in the differential diagnosis of muscle stiffness. It is important to perform. Detailed investigations are essential to determine whether an underlying cause exists.

  • Open Access

    Lower Urinary Tract Symptoms in Male Patients With Multiple Sclerosis: Prevalence and Associations With Quality of Life, Depression, and Anxiety

    by Yesim Akkoc, Bedriye Karaman, Asli Koskderelioglu, Ozgul Ekmekci, Neslihan Eskut, Nur Yuceyar

    Purpose: Lower urinary tract symptoms (LUTS) are frequent in male patients with multiple sclerosis (MS). This study was planned to investigate the frequency and distress of LUTS in men with MS and their association with quality of life (QoL), depression, and anxiety. Methods: One hundred male patients with MS were included in the study. The International Incontinence Consultation Questionnaire‐Male LUTS questionnaire (ICIQ‐MLUTS) was used to investigate LUTS. The King's Health questionnaire (KHQ) was used to evaluate QoL and the Hospital Anxiety and Depression (HAD‐A, HAD‐D) scale was used to evaluate depression and anxiety. Results: A total of 100 men with an average age of 39.3 ± 9.3 (range, 20−63) years were evaluated. The mean disease duration was 9.3 ± 6.0 (range, 1−26) years. The mean EDSS score was 2.2 ± 1.8 (median: 2, range: 0−6.5). A total of 91% of patients reported at least one LUTS. The most common storage symptoms were urgency and urgency urinary incontinence (IU), and the most common voiding symptoms were incomplete emptying, hesitancy, and intermittency. ICIQ‐MLUTS incontinence and voiding scores were significantly correlated with disease duration, EDSS, HAD‐A, HAD‐D, and all KHQ subgroups, except general health perceptions. Conclusions: LUTS, including storage and voiding symptoms, were highly prevalent in male MS patients and significantly correlated with reduced QoL, increased HAD‐D and HAD‐A scores.


  • Open Access

    Is impairment of facial emotion recognition independent of cognitive dysfunction in multiple sclerosis?

    by Yagmur Simge Sever Aktuna, Asli Koskderelioglu, Neslihan Eskut, Atalay Aktuna

    Background: Emotions expressed on the face play a key role in social cognition and communication by providing inner emotional experiences. This study aimed to evaluate facial emotion identification and discrimination and empathy abilities in patients with MS and whether it is related to cognitive dysfunction. Methods: One hundred twenty patients with relapsing–remitting MS and age- and sex-matched 120 healthy controls were enrolled in the study. All the subjects were evaluated with the Facial Emotion Identification Test (FEIT), Facial Emotion Discrimination Test (FEIDT), and Empathy Quotient (EQ). We used the Beck Depression Inventory (BDI) for depression and detailed cognitive tests, including the Montreal Cognitive Assessment (MoCA), the Symbol Digit Modalities Test (SDMT), and the Paced Auditory Serial Addition Test (PASAT). The quality of life was assessed with Multiple Sclerosis Quality of Life-54 (MSQL-54). Results: Patients with MS were 37.6 ± 9.5 years old, had a mean disease duration of 8.8 ± 6.6 (8–28) years, and a mean EDSS score of 1.6 ± 1.3 (0–4.5). We found significant differences in the identification of facial emotions, discrimination of facial emotions, and empathy in MS patients compared to controls (p < 0.05). Especially the recognition of feelings of sadness, fear, and shame was significantly lower in MS patients. The multivariate logistic regression analysis showed low SDMT and FEIDT scores which showed an independent association with MS. Conclusions: Our findings indicate that facial emotion recognition and identification deficits are remarkable among patients with MS and emotion recognition is impaired together with and independently of cognitive dysfunction in MS patients.


  • Open Access

    Cinsel ve nörojenik alt üriner sistem disfonksiyonunun multipl skleroz hastalarının yaşam kalitesi ve sağlık algıları üzerindeki etkisi

    by Neslihan Eşkut, Aslı KÖŞKDERELİOĞLU

    Purpose: To investigate the impact of neurogenic lower urinary tract dysfunction (NLUTD) and sexual dysfunction (SD) on multiple sclerosis (MS) patients' quality of life and health perceptions and evaluate the possible relationship with disease parameters. Materials and Methods: A total of 192 patients with MS were included in the study. Along with the King's Health (KHQ) and COOP/WONCA questionnaires, Arizona Sexual Experience Scale (ASEX), Beck Depression Scale (BDI), Monitoring My Multiple Sclerosis Scale (MMMS) were used to evaluate the patients’ quality of life and self-perception of health. Results: The median age of the patients was 39.5 years (18–66 years). In contrast, SD was present in 34.4%, 51.6% of the patients presented with NLUTD. Patients with NLUTD had significant differences in terms of age, education level, duration of disease, EDSS, BDI, ASEX, and MMMS scores. The majority of the study group had minor disability (82.8% had an EDSS score less than 3). Patients with SD showed higher disability, depression, and disrupted self-perception of their health status. In addition, quality of life measures correlated with the presence of NLUTD, SD and depression along with higher disability and altered self perception of their health status. Conclusion: NLUTD and SD significantly effect quality of life and well being. Increasing awareness about the impact of NLUTD and SD symptoms in patients with MS will provide a comprehensive approach in clinical practice.

  • Fall risk is related to cognitive functioning in ambulatory multiple sclerosis patients

    by Yaprak Ozum Unsal Bilgin, Asli Koskderelioglu, Muhtesem Gedizlioglu

    Background and aims Patients with multiple sclerosis (PwMS) may suffer severely from falling and gait disturbance. Cognitive dysfunction, a common condition in MS patients, may also increase falling rates, regardless of physical disability. We planned this study to determine the fall rate and risk factors in MS patients, follow patients for falls, and reveal the relationship between falls and cognitive dysfunction. Methods The study was conducted on 124 patients who have RRMS diagnoses. Patients' gait speed, simultaneous gait speed during other tasks, functions of the upper extremity, balance rating, and fear of falling were evaluated with dual-task Timed-Up-and-Go-3 versions (TUG, TUG-C, TUG-M), Timed 25 Foot Walk (T25WFT), Nine Hole Peg Test (9HPT), Berg Balance Scale (BBS) and Falls Efficacy Scale-International (FES-I) tests. Cognitive functions, fatigue levels, and quality of life were measured with the Symbol Digit Modalities Test (SDMT), Fatigue Severity Scale (FSS), and Multiple Sclerosis Quality of Life (MSQoL) test. Two groups were formed as "fallers" and "non-faller patients". We monitored the patients in six months period. Results Forty-six patients fell at least once in the last one year before the study began. Fallers were older, less educated, had lower SDMT scores and higher disability scores. Non-faller patients scored lower in FES-I, TUG, and FSS tests. SDMT scores showed statistically significant, linear, positive, and moderate correlation with BBS and 9HPT scores (r = 0.307, p = 0.038, and r = 0.320, p = 0.030, respectively). Conclusion We determined that advanced age, lower education level, and cognitive dysfunction adversely affect gait speed and balance. Among the fallers, those with lower SDMT and MoCA scores had higher falling rates. We determined that EDSS and BBS scores are predictive factors for falls in patients with MS. In conclusion, patients with cognitive impairment should be closely monitored for the risk of falling. Consideration of falls during follow-up examinations might be predictive of cognitive deterioration in patients with MS.


  • Open Access

    Correlation of brain segmental volume changes with clinical parameters: a longitudinal study in multiple sclerosis patients

    by Neslihan Eskut, Ali Murat Koc, Asli Koskderelioglu, Ismail Dilek, Mustafa Agah Tekindal

    Objective To measure the cranial volume differences from 15 different parts in the follow-up of relapsing-remitting multiple sclerosis (RRMS) patients and correlate them with clinical parameters. Methods Forty-seven patients with RRMS were included in the study. Patients were grouped into two categories; low Expanded Disability Status Scale (EDSS) (< 3; group 1), and moderate-high EDSS (≥ 3; group 2). Patients were evaluated with Beck Depression Inventory (BDI), Montreal Cognitive Assessment (MOCA), Symbol Digit Modalities Test (SDMT), Fatigue Severity Scale (FSS), and calculated Annualized Relapse Rate (ARR) scores. Magnetic resonance imaging (MRI) was performed with a 1.5T MRI device (Magnetom AERA, Siemens, Erlangen, Germany) twice in a 1-year period. Volumetric analysis was performed by a free, automated, online MRI brain volumetry software. The differences in volumetric values between the two MRI scans were calculated and correlated with the demographic and clinical parameters of the patients. Results The number of attacks, disease duration, BDI, and FSS scores were higher in group 2; SDMT was higher in group 1. As expected, volumetric analyses have shown volume loss in total cerebral white matter in follow-up patients (p < 0.001). In addition, putaminal volume loss was related to a higher number of attacks. Besides, a negative relation between FSS with total amygdala volumes, a link between atrophy of globus pallidus and ARR, and BDI scores was found with the aid of network analysis. Conclusions Apart from a visual demonstration of volume loss, cranial MRI with volumetric analysis has a great potential for revealing covert links between segmental volume changes and clinical parameters.